CXCL12 N-terminal end is sufficient to induce chemotaxis and proliferation of neural stem/progenitor cells.
Stem Cell Res
; 11(2): 913-25, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23851289
ABSTRACT
Neural stem/progenitor cells (NSC) respond to injury after brain injuries secreting IL-1, IL-6, TNF-α, IL-4 and IL-10, as well as chemokine members of the CC and CXC ligand families. CXCL12 is one of the chemokines secreted at an injury site and is known to attract NSC-derived neuroblasts, cells that express CXCL12 receptor, CXCR4. Activation of CXCR4 by CXCL12 depends on two domains located at the N-terminal of the chemokine. In the present work we aimed to investigate if the N-terminal end of CXCL12, where CXCR4 binding and activation domains are located, was sufficient to induce NSC-derived neuroblast chemotaxis. Our data show that a synthetic peptide analogous to the first 21 amino acids of the N-terminal end of CXCL12, named PepC-C (KPVSLSYRCPCRFFESHIARA), is able to promote chemotaxis of neuroblasts in vivo, and stimulate chemotaxis and proliferation of CXCR4+ cells in vitro, without affecting NSC fate. We also show that PepC-C upregulates CXCL12 expression in vivo and in vitro. We suggest the N-terminal end of CXCL12 is responsible for a positive feedback loop to maintain a gradient of CXCL12 that attracts neuroblasts from the subventricular zone into an injury site.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Quimiotaxia
/
Quimiocina CXCL12
/
Células-Tronco Neurais
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Stem Cell Res
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Brasil